RecallDepth
Class II Ongoing

Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98

Company
Cipla Usa, Inc.
Recall Initiated
October 23, 2024
Posted
November 20, 2024
Recall Number
D-0043-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1,875 boxes (cipla and exlan)
Firm Location
Warren, NJ, United States

Reason for Recall

Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.

Distribution

USA nationwide.

Lot / Code Info

Lot # NB240316, Exp 12/31/25

More recalls by Cipla Usa, Inc.

View all recalls by this company →

Other recent Class II Drug recalls